2
Dear colleagues, We are pleased to announce the 3 rd International Workshop on Clinical Pharmacology of Anticancer Drugs, is scheduled to take place on 8-9 November 2018 in Amsterdam, the Netherlands. The field of anticancer drugs is in continuous development. Given the many existing drugs with multiple unanswered pharmacological questions and with the introduction of the new group of agents with their unique pharmacological properties many studies are being performed which will lead to new perspectives. This meeting offers a platform for indepth discussion and debate among experts on new data and their implications. We invite you to attend the International Workshop on Clinical Pharmacology of Anticancer Drugs in Amsterdam. We look forward to greeting you. Organizing Committee Etienne Chatelut PharmD, PhD University Institute Cancer Toulouse Oncopole, France Maria J. Garrido PhD University of Navarra, Spain George Demetri MD Harvard Medical School, USA Howard Gurney MBBS, FRACP Westmead Hospital, Australia Nielka van Erp PharmD, PhD Radboud University Medical Centre, the Netherlands Ron Mathijssen MD, PhD Erasmus Medical Centre, the Netherlands Lena Friberg PhD Uppsala University, Sweden Michelle Rudek PharmD, PhD Johns Hopkins University, USA 3 RD INTERNATIONAL WORKSHOP ON AMSTERDAM, THE NETHERLANDS 8 - 9 NOVEMBER 2018 CLINICAL PHARMACOLOGY OF ANTICANCER DRUGS expert medical events THIS MEETING IS ORGANIZED BY: www.expertmedicalevents.com REVISIT THE 2017 EDITION Want to see more? Visit Infectious Diseases Online: infectiousdiseasesonline.com Gain access to all the meeting presentations, webcasts, abstracts, and more! WHO SHOULD ATTEND? Medical oncologists, internal medicine doctors, clinical pharmacologists, hospital pharmacists, industry researchers, government representatives and other experts involved in this field of research. ORGANIZING COMMITTEE

3 INTERNATIONAL WORKSHOP ON CLINICAL PHARMACOLOGY …regist2.virology-education.com/Flyer/2018/ICPAD.pdf · Dear colleagues, We are pleased to announce the 3 rdInt ernational Workshop

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 3 INTERNATIONAL WORKSHOP ON CLINICAL PHARMACOLOGY …regist2.virology-education.com/Flyer/2018/ICPAD.pdf · Dear colleagues, We are pleased to announce the 3 rdInt ernational Workshop

Dear colleagues,

We are pleased to announce the 3rd International Workshop on Clinical Pharmacology of Anticancer Drugs, is scheduled to take place on 8-9 November 2018 in Amsterdam, the Netherlands.

The field of anticancer drugs is in continuous development. Given the many existing drugs with multiple unanswered pharmacological questions and with the introduction of the new group of agents with their unique pharmacological properties many studies are being performed which will lead to new perspectives. This meeting offers a platform for indepth discussion and debate among experts on new data and their implications.

We invite you to attend the International Workshop on Clinical Pharmacology of Anticancer Drugs in Amsterdam.

We look forward to greeting you.Organizing Committee

Etienne ChatelutPharmD, PhD University Institute Cancer Toulouse Oncopole, France

Maria J. GarridoPhD University of Navarra, Spain

George DemetriMD Harvard Medical School, USA

Howard GurneyMBBS, FRACP Westmead Hospital, Australia

Nielka van ErpPharmD, PhD Radboud University Medical Centre, the Netherlands

Ron MathijssenMD, PhD Erasmus Medical Centre, the Netherlands

Lena FribergPhD Uppsala University, Sweden

Michelle RudekPharmD, PhD Johns Hopkins University, USA

3RD INTERNATIONAL WORKSHOP ON

AMSTERDAM, THE NETHERLANDS • 8 - 9 NOVEMBER 2018

CLINICAL PHARMACOLOGY OF ANTICANCER DRUGS

expertmedical events

THIS MEETING IS ORGANIZED BY:

www.expertmedicalevents.com

REVISIT THE 2017 EDITION

Want to see more? Visit Infectious Diseases Online: infectiousdiseasesonline.comGain access to all the meeting presentations, webcasts, abstracts, and more!

WHO SHOULD ATTEND?

Medical oncologists, internal medicine doctors, clinical pharmacologists, hospital pharmacists, industry researchers, government representatives and other experts involved in this field of research.

ORGANIZING COMMITTEE

Page 2: 3 INTERNATIONAL WORKSHOP ON CLINICAL PHARMACOLOGY …regist2.virology-education.com/Flyer/2018/ICPAD.pdf · Dear colleagues, We are pleased to announce the 3 rdInt ernational Workshop

MEETING OBJECTIVES

• To gather professionals in the field of pharmacology of anticancer drugs in an interactive workshop setting;

• To provide a platform for presentation and discussion of the latest pharmacological developments in the field;

• To map current studies and latest results;

• To translate new data into treatment opportunities;

• To educate clinicians on pharmacological challenges that need to be addressed with the implementation of current and new drugs.

expertmedical events www.expertmedicalevents.com

MORE INFORMATION

Abstract submission is open until 1 September

Complimentary registration for young investigators with an accepted abstract.

ABSTRACT TOPICS

• Pharmacokinetics and pharmacodynamics of anticancer drugs

• Population pharmacokinetics & pharmacokinetic-pharmacodynamic modeling

• Drug development and optimization: approaches & tools

• Drug-drug and drug-disease state interactions

• Anticancer drug therapies in special populations

Registration is openEarly registration discount is available until 7 March.

ENDORSERS

Members of endorsing organizations enjoy addtional 25% discount on registration fees.

SPONSORS

Contributor level

Session topics:• Pharmacological challenges of immunotherapeutics

• Combination therapy – old school is becoming new school again

• Dose individualization approaches

• Drug-Drug / Drug-Food / Drug-Environmental interactions

• Approaches to shorten phase II studies by the use of different read out endpoints

• PK/PD studies and new strategies